Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring
Analytical Methods · 2026
DOI: 10.1039/d6ay00331a ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Methods, 2026. Verfasst von Stefania Federico und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Antimicrobial Optimisation, Imperial College London, London, UK. alaa.riezk@imperial.ac.uk. Hauptthemen laut MEDLINE: Meropenem, Tandem Mass Spectrometry, Piperacillin, Drug Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Wellcome Trust, NIHR Imperial Biomedical Research Centre, National Institute for Health Research Health Protection Research Unit.
Abstract (Originalsprache)
A highly sensitive LC-MS/MS method (LLOQ 0.02 mg L −1 ) enables simultaneous quantification of piperacillin, tazobactam and meropenem for therapeutic drug monitoring in critically ill patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Antimicrobial Optimisation, Imperial College London, London, UK. alaa.riezk@imperial.ac.uk.
- Pharmacy Department, Imperial College Healthcare NHS Trust, London, UK.
- National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
- David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool, UK.
- OPAT Service, Imperial College Healthcare NHS Trust, London, UK.
- Fleming Initiative, Fleming Centre, Imperial College London and Imperial College Healthcare NHS Trust, London, UK.
ORCID-Profile: Alaa Riezk
Förderung
- Wellcome Trust
- NIHR Imperial Biomedical Research Centre
- National Institute for Health Research Health Protection Research Unit
- Imperial College London
- Public Health England
- NIHR Sheffield Clinical Research Facility
- Imperial College Healthcare NHS Trust
Zitieren
APA
Federico, S., Williams, S., Wilson, R. C., Arkel, P., Gilchrist, M. J., Holmes, A. H., Rawson, T. M., & Riezk, A. (2026). Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring. Analytical Methods. https://doi.org/10.1039/d6ay00331a
Vancouver
Federico S, Williams S, Wilson RC, Arkel P, Gilchrist MJ, Holmes AH, et al. Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring. Analytical Methods. 2026. doi:10.1039/d6ay00331a
BibTeX
@article{Federico2026,
author = {Federico, Stefania and Williams, Suzy and Wilson, Richard C and Arkel, Paul and Gilchrist, Mark J and Holmes, Alison H and Rawson, Timothy M and Riezk, Alaa},
title = {Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring},
journal = {Analytical Methods},
year = {2026},
doi = {10.1039/d6ay00331a}
}
EUVIMED